Bank of New York Mellon Corp - ANAPTYSBIO INC ownership

ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 122 filers reported holding ANAPTYSBIO INC in Q3 2019. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ANAPTYSBIO INC
ValueSharesWeighting
Q2 2024$1,867,221
+29.4%
74,510
+16.3%
0.00%
Q1 2024$1,443,240
-3.8%
64,087
-8.5%
0.00%
Q4 2023$1,500,172
+20.3%
70,036
+0.9%
0.00%
Q3 2023$1,246,514
-11.7%
69,405
+0.0%
0.00%
Q2 2023$1,411,209
-14.7%
69,381
-8.7%
0.00%
Q1 2023$1,653,846
-30.7%
76,004
-1.4%
0.00%
-100.0%
Q4 2022$2,387,686
+11.3%
77,047
-8.4%
0.00%0.0%
Q3 2022$2,146,000
+36.9%
84,104
+8.9%
0.00%
Q2 2022$1,567,000
-25.2%
77,242
-8.8%
0.00%
Q1 2022$2,096,000
-29.5%
84,715
-1.0%
0.00%
-100.0%
Q4 2021$2,974,000
+33.7%
85,580
+4.3%
0.00%
Q3 2021$2,225,000
+8.8%
82,036
+4.0%
0.00%
Q2 2021$2,045,000
-5.5%
78,851
-21.5%
0.00%
Q1 2021$2,164,000
+0.6%
100,429
+0.3%
0.00%
Q4 2020$2,151,000
+38.0%
100,086
-5.3%
0.00%
Q3 2020$1,559,000
-35.6%
105,730
-2.4%
0.00%
-100.0%
Q2 2020$2,420,000
+63.7%
108,326
+3.5%
0.00%
Q1 2020$1,478,000
-9.4%
104,665
+4.3%
0.00%
Q4 2019$1,631,000
-53.2%
100,395
+0.8%
0.00%
-100.0%
Q3 2019$3,485,000
-38.2%
99,583
-0.4%
0.00%
-50.0%
Q2 2019$5,643,000
-11.9%
100,005
+14.0%
0.00%0.0%
Q1 2019$6,406,000
+17.4%
87,700
+2.5%
0.00%0.0%
Q4 2018$5,455,000
-38.5%
85,530
-3.7%
0.00%0.0%
Q3 2018$8,864,000
+48.7%
88,847
+5.8%
0.00%0.0%
Q2 2018$5,963,000
-26.2%
83,947
+8.2%
0.00%0.0%
Q1 2018$8,076,000
-13.2%
77,592
-16.1%
0.00%0.0%
Q4 2017$9,309,000
+596.3%
92,430
+141.7%
0.00%
Q3 2017$1,337,000
+182.7%
38,241
+93.7%
0.00%
Q2 2017$473,000
+26.8%
19,744
+46.8%
0.00%
Q1 2017$373,00013,4470.00%
Other shareholders
ANAPTYSBIO INC shareholders Q3 2019
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,628,678$91,347,00018.37%
EcoR1 Capital, LLC 7,521,024$261,356,0008.33%
GREAT POINT PARTNERS LLC 592,250$20,581,0004.57%
FRAZIER MANAGEMENT LLC 899,700$31,265,0002.41%
Boxer Capital, LLC 1,300,000$45,175,0001.76%
Palo Alto Investors LP 436,592$15,172,0000.97%
Rock Springs Capital Management LP 538,700$18,720,0000.43%
Eversept Partners, LP 182,612$6,345,7670.40%
EAM Global Investors LLC 58,683$2,039,0000.36%
Woodline Partners LP 609,981$21,197,0000.30%
View complete list of ANAPTYSBIO INC shareholders